| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.491 | 1.396 | 853 | 394 | 1.000 |
| Total Income - EUR | - | - | - | - | - | 12.124 | 3.209 | 853 | 394 | 1.003 |
| Total Expenses - EUR | - | - | - | - | - | 35.553 | 14.999 | 7.476 | 6.147 | 5.916 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -23.429 | -11.790 | -6.622 | -5.753 | -4.913 |
| Net Profit/Loss - EUR | - | - | - | - | - | -23.532 | -11.835 | -6.632 | -5.753 | -4.913 |
| Employees | - | - | - | - | - | 2 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Laborator Flavior S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 26.195 | 19.552 | 13.532 | 7.550 | 1.961 |
| Current Assets | - | - | - | - | - | 3.781 | 2.490 | 3.215 | 3.424 | 3.113 |
| Inventories | - | - | - | - | - | 347 | 1.145 | 1.452 | 1.522 | 1.513 |
| Receivables | - | - | - | - | - | 2.336 | 1.345 | 1.752 | 1.726 | 1.519 |
| Cash | - | - | - | - | - | 1.098 | 0 | 11 | 176 | 81 |
| Shareholders Funds | - | - | - | - | - | -29.030 | -40.222 | -46.979 | -52.588 | -57.208 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 22.997 | 28.865 | 30.223 | 30.161 | 29.068 |
| Income in Advance | - | - | - | - | - | 36.010 | 33.399 | 33.503 | 33.401 | 33.215 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1072 - 1072" | |||||||||
| CAEN Financial Year |
1072
|
|||||||||
Comments - Laborator Flavior S.r.l.